Douglas Instruments Microbatch seminar- slide 1 Introduction to microbatch protein crystallization Patrick Shaw Stewart Imperial College, London: Professor David M. Blow, Patrick Shaw Stewart, Dennis Maeder, Naomi Chayen Douglas Instruments Limited (near Oxford, UK): Peter Baldock, Patrick Shaw Stewart, Vaughan Mills, James Smith
86
Embed
Introduction to microbatch protein crystallization Patrick Shaw Stewart Imperial College, London:
Introduction to microbatch protein crystallization Patrick Shaw Stewart Imperial College, London: Professor David M. Blow, Patrick Shaw Stewart, Dennis Maeder, Naomi Chayen Douglas Instruments Limited (near Oxford, UK): Peter Baldock, Patrick Shaw Stewart, Vaughan Mills, James Smith. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 1
Introduction to microbatch protein crystallization
Patrick Shaw Stewart
Imperial College, London:Professor David M. Blow, Patrick Shaw Stewart, Dennis Maeder, Naomi Chayen
Douglas Instruments Limited (near Oxford, UK):Peter Baldock, Patrick Shaw Stewart, Vaughan Mills, James Smith
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 2
What is microbatch crystallization?
• Crystallization in small drops under oil
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 3
What is microbatch crystallization?
• Crystallization in small drops under oil
• 100 + 100 nl to 1+1 µl
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 4
What is microbatch crystallization?
• Crystallization in small drops under oil
• 100 + 100 nl to 1+1 µl
• The oil prevents evaporation
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 5
Why is microbatch a good idea?
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 6
Why is microbatch a good idea?
1. Easy
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 7
Why is microbatch a good idea?
1. Easy
2. Gives better crystals in many cases – especially in screening
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 8
Why is microbatch a good idea?
1. Easy
2. Gives better crystals in many cases – especially in screening
3. It doesn’t matter if the security guard at the airport puts it through the x-ray machine upside down
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 9
Why is microbatch a good idea?
1. Easy
2. Gives better crystals in many cases – especially in screening
3. It doesn’t matter if the security guard at the airport puts it through the x-ray machine upside down
• Suck up protein required for experiment + 0.25 µl
• Suck air bubble in second bore – for transfer
Air bubble
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 27
Microbatch screening – “sip and spit”
(1)(1)1. Pick up 100 nl screening solution
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 28
Microbatch screening – “sip and spit”
(2)(2) (1)(1)1. Pick up 100 nl screening solution
2. Transfer to microbatch drop and add protein
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 29
Microbatch optimization
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 30
5-bore Microtip – optimization
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 31
Microbatch optimization – dispensing cycle
(1)(1)1. Dispense five
solutions together
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 32
Microbatch optimization – dispensing cycle
(2) oil(2) oil1. Dispense five solutions together
2. Oil
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 33
Central Composite design
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 34
Sitting Drop – dispensing cycle
1. Rinse in reservoir
2. Move sideways and pick up clean solution
3. Dispense solution and protein (2)(2)
(1)(1)
(3)(3)
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 35
Phase diagram of a protein
[Protein]
[Precipitant]
clear
precipitate
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 36
Phase diagram of a protein
[Protein]
[Precipitant]
clear
precipitate
nucleation
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 37
Phase diagram of a protein
[Protein]
[Precipitant]
clear
precipitate
nucleation
metastable zone
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 38
Phase diagram of a protein
[Protein]
[Precipitant]
c
p
n
m.z. Vapor diffusion
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 39
Phase diagram of a protein
[Protein]
[Precipitant]
c
p
n
m.z. v.d.
Microbatch
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 40
Phase diagram of a protein
[Protein]
[Precipitant]
c
p
n
m.z. v.d..
M.B.(paraffin)
M.B.(par./si.)
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 41
Phase diagram of a protein
[Protein]
[Precipitant]
p
n
m.z. v.d.
M.B.(paraffin)
OPTIMIZATION
M.B.(par./si.)
SCREENING
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 42
What % of protein should you use?
[Protein]
[Precipitant]
n
m.z.
Microbatch with Si. / Par.:
Precipitant saturated
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 43
What % of protein should you use?
[Protein]
[Precipitant]
n
m.z.
Microbatch with Si. / Par.:
Protein stock
Precipitant stock
Precipitant saturated
50%
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 44
What % of protein should you use?
[Protein]
[Precipitant]
n
m.z.
Microbatch with Si. / Par.:
Protein stock
Precipitant stock
Precipitant saturated
50%66%
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 45
Screening: studies comparing microbatch with vapor diffusion
Proteins
Conditions MB VD
Extra hits for
MB
Extra hits for
MB %
Unique to MB
Unique to VD
1996
Baldock et al.
Douglas Ins. 6 48 43 41 2 5% 17 15
P.F.M. Baldock, V. Mills, P.D. Shaw Stewart. A comparison of microbatch and vapour diffusion for initial screening of crystallization conditions. Journal of Crystal Growth. 168 (1996), pp 170-174 or: http://www.douglas.co.uk/rep2.htm
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 46
Screening: studies comparing microbatch with vapor diffusion
Proteins
Conditions MB VD
Extra hits for
MB
Extra hits for
MB %
Unique to MB
Unique to VD
1996
Baldock et al.
Douglas Ins. 6 48 43 41 2 5% 17 15
2000
D'Arcy et al.
Hoffman-La Roche 10 48 104 62 42 68%
P.F.M. Baldock, V. Mills, P.D. Shaw Stewart. A comparison of microbatch and vapour diffusion for initial screening of crystallization conditions. Journal of Crystal Growth. 168 (1996), pp 170-174 or: http://www.douglas.co.uk/rep2.htm
A. D’Arcy, G.E. Dale, M. Stihle, B. D’Arcy. Results reported at the 8th International Conference on the Crystallization of Biological Macromolecules, May 18, 2000.
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 47
Screening: studies comparing microbatch with vapor diffusion
Proteins
Conditions MB VD
Extra hits for
MB
Extra hits for
MB %
Unique to MB
Unique to VD
1996
Baldock et al.
Douglas Ins. 6 48 43 41 2 5% 17 15
2000
D'Arcy et al.
Hoffman-La Roche 10 48 104 62 42 68%
2001
Noordeen et al.
Novartis Pharma 8 48 - 576 145 153 -8 -5% 95 103
P.F.M. Baldock, V. Mills, P.D. Shaw Stewart. A comparison of microbatch and vapour diffusion for initial screening of crystallization conditions. Journal of Crystal Growth. 168 (1996), pp 170-174 or: http://www.douglas.co.uk/rep2.htm
A. D’Arcy, G.E. Dale, M. Stihle, B. D’Arcy. Results reported at the 8th International Conference on the Crystallization of Biological Macromolecules, May 18, 2000.
N. Noordeen and S. Cowan-Jacob. Novartis Pharma AG. http://www.hamptonresearch.com/stuff/ppt_files/P6.ppt
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 48
Screening: studies comparing microbatch with vapor diffusion
Proteins
Conditions MB VD
Extra hits for
MB
Extra hits for
MB %
Unique to MB
Unique to VD
1996
Baldock et al.
Douglas Ins. 6 48 43 41 2 5% 17 15
2000
D'Arcy et al.
Hoffman-La Roche 10 48 104 62 42 68%
2001
Noordeen et al.
Novartis Pharma 8 48 - 576 145 153 -8 -5% 95 103
Sugahara SPring8 6 288 100 84 16 19%
P.F.M. Baldock, V. Mills, P.D. Shaw Stewart. A comparison of microbatch and vapour diffusion for initial screening of crystallization conditions. Journal of Crystal Growth. 168 (1996), pp 170-174 or: http://www.douglas.co.uk/rep2.htm
A. D’Arcy, G.E. Dale, M. Stihle, B. D’Arcy. Results reported at the 8th International Conference on the Crystallization of Biological Macromolecules, May 18, 2000.
N. Noordeen and S. Cowan-Jacob. Novartis Pharma AG. http://www.hamptonresearch.com/stuff/ppt_files/P6.ppt
Misuaki Sugahara, Riken Harima Institute, SPring8. Personal communication.
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 49
Screening: studies comparing microbatch with vapor diffusion
Proteins
Conditions MB VD
Extra hits for
MB
Extra hits for
MB %
Unique to MB
Unique to VD
1996
Baldock et al.
Douglas Ins. 6 48 43 41 2 5% 17 15
2000
D'Arcy et al.
Hoffman-La Roche 10 48 104 62 42 68%
2001
Noordeen et al.
Novartis Pharma 8 48 - 576 145 153 -8 -5% 95 103
Sugahara SPring8 6 288 100 84 16 19%
TOTAL 30 392 340 52 15% P.F.M. Baldock, V. Mills, P.D. Shaw Stewart. A comparison of microbatch and vapour diffusion for initial screening of crystallization conditions. Journal of Crystal Growth. 168 (1996), pp 170-174 or: http://www.douglas.co.uk/rep2.htm
A. D’Arcy, G.E. Dale, M. Stihle, B. D’Arcy. Results reported at the 8th International Conference on the Crystallization of Biological Macromolecules, May 18, 2000.
N. Noordeen and S. Cowan-Jacob. Novartis Pharma AG. http://www.hamptonresearch.com/stuff/ppt_files/P6.ppt
Misuaki Sugahara, Riken Harima Institute, SPring8. Personal communication.
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 50
OPTIMIZATION: about 50:50
• In microbatch, there tends to be more precipitation initially; this may result in more nucleation
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 51
OPTIMIZATION: about 50:50
• In microbatch, there tends to be more precipitation initially; this may result in more nucleation
• In a survey of about 30 protein samples at Imperial College, London, the best data was collected from MB in 50% of cases
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 52
OPTIMIZATION: about 50:50
• In microbatch, there tends to be more precipitation initially; this may result in more nucleation
• In a survey of about 30 protein samples at Imperial College, London, the best data was collected from MB in 50% of cases
• Lesley Haire (NIMR, London) told me that out of 20 structures solved in the last few years, 5 relied on microbatch
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 53
OPTIMIZATION: about 50:50
From D’Arcy et al. A novel approach to crystallising proteins under oil. Journal of Crystal Growth 168 (1996) 175-180.
Vapor diffusion
Microbatch
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 54
Crystals obtained at 4ºC(Lesley Haire, Imperial College)
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 55
Crystals nucleated for 1 hr 4ºC, then grown at 18ºC
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 56
Case Study 2
Use of microseeding Yaakov Korkhin and Artem Evdokimov, Weizmann Institute of
Science, Israel
A newly isolated alcohol dehydrogenase from a thermophile was crystallized with PEG 4000, pH 5.5 - 8.6
• VD crystals grew very rapidly and were poorly formed
• MB crystals were initially similar
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 57
[Protein]
[Precipitant]
p
m.z.
1. Determination of phase diagram
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 58
A few good quality crystals were obtained
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 59
[Protein]
[PEG 4K]
Edge of nucleation – 16 % PEG
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 60
2. Microseeding was used
1. A well-formed crystal was broken up in 15.5% PEG
2. The mixture was spun
3. A series of dilutions was set up using the supernatant (1:1000 worked best)
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 61
[Protein]
[PEG 4K]
Reservoir – 16.5 %Droplet – 15.5 %
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 62
Reproducible good quality crystals wereobtained with microseeding. Crystals diffracted to 2Å
Dou
gla
s
Instr
um
en
ts
Microbatch seminar- slide 63
Exactly the same conditions – but with no seeding solution - gave poor crystals